Pediatric Drug Development & Therapeutics in September TIRS

Our September issue of TIRS features a Special Section on Pediatric Therapeutics, a remarkable series of articles on pediatric drug development and therapeutics -- from new genomic targets for drug discovery, to new clinical trial paradigms, to formulation acceptability validation, to patient-centric global networks, to a comprehensive view of pediatric regulatory requirements. Stephen P. Spielberg, MD, PhD, FAAP, and Ronald Portman, MD, FAAP, discuss this amazing collection of articles, all in one convenient place, to help inform the future of pediatric drug development.